Drug Regulatory News | CDE Issues Notices on "Major Deficiencies in Pharmaceutical Research of Chemical Generic Drugs" and "Major Deficiencies in Bioequivalence Research of Chemical Generic Drugs"
2026/05/21
- Pre：Officially implemented on May 1st: Detailed Rules for Order No. 818 | Notice of the National Health Commission on the Issuance of Work Standards for the Approval of Clinical Translation and Applicatio
- Next：Forward | Notice from the Office of the National Medical Products Administration on Holding a Training Course on Reproductive and Genetic Toxicity Evaluation Strategies and Case Sharing
